Concentrations of nicotine in plasma were determined using gas chromatography-mass spectrometry (GC-MS) [1], modified for analysis using a triple quadrupole mass spectrometer.
(LC-MS/MS) [3] . A brief description is as follows: the internal standard, NNAL-d 3 was added, and the samples were incubated with beta-glucuronidase enzyme to cleave the conjugates for determination of total NNAL. The analyte was extracted using a liquid/liquid extraction procedure, and converted to the hexanoate ester derivative. Following chromatography using a gradient elution, the analyte was quantitated using electrospray ionization (ESI) and selected reaction monitoring (SRM). The lower limit of quantitation (LLOQ) is 0.25 pg/mL (0.0012 pmol/mL).
PAH Metabolites in Urine
PAHs (polycyclic aromatic hydrocarbons) are a major class of carcinogens formed by incomplete combustion. PAH metabolites were also determined using LC-MS/MS. [4] Briefly, stable isotope-labeled internals standards were added, and the samples were incubated with betaglucuronidase enzyme to cleave the conjugates. Following a liquid/liquid extraction, the analytes were converted to pentafluorobenzyl derivatives. The analytes are separated using a gradient elution, and quantitated using electron capture atmospheric pressure chemical ionization (ECAPCI) and SRM. The LLOQ for 2-naphthol is 0.25 ng/mL; the LLOQs for the other analytes are 0.025 ng/mL.
Mercapturic Acid Metabolites of VOCs
Tobacco smoke contains carcinogenic volatile organic compounds (VOCs), and many of these are metabolized by conjugation with glutathione and excretion as mercapturic acids, which can be useful biomarkers. Mercapturic acid metabolites of VOCs were determined by LC-MS/MS using electron capture atmospheric pressure chemical ionization (ECAPCI), using the same principle to enhance detection as described in our PAH method described above.
Instrumentation. LC-MS/MS analyses were carried out with an Agilent (Palo Alto, CA ) 1200 HPLC interfaced to a Thermo-Finnigan (San Jose, CA) TSQ Quantum Ultra triple-stage quadrupole mass spectrometer, with an atmospheric pressure chemical ionization (APCI) source.
Standards and Reagents. Mercapturic acid standards and deuterium-labeled internal standards
were obtained from Toronto Research Chemicals, North York, Ontario, Canada, or were synthesized in our laboratory. HPLC grade methanol and water from Honeywell/Burdick and Jackson (Muskegon, MI) were used to prepare the LC mobile phase. Methylene chloride, isopropyl alcohol, ethyl acetate, and pentane used for extractions were HPLC or Optima grade from Fisher Scientific (Fair Lawn, New Jersey). Pentafluorobenzyl bromide and N,Ndiisopropylethylamine were obtained from Aldrich Chemical Company (Milwaukee, WI).
Preparation of Standards and Controls. Standards were prepared by spiking "artificial urine" [4] with the analytes at ten concentrations spanning the expected range. Pooled urine from 3 non-smokers was used to prepare quality control samples. Standards and controls were stored frozen at -20°C until use.
Sample Preparation. Deuterium-labeled internal standards in 50 µL water were added to 1 mL standards in artificial urine or to 1 mL urine samples followed by 0.9 mL of saturated potassium bromide and 0.1 mL saturated potassium hydrogen sulfate. They were then extracted with a mixture of methylene chloride, isopropyl alcohol, and ethyl acetate (1:1:1, 3 mL). The extracts were evaporated using a stream of nitrogen at 60° C, and the analytes were converted to pentafluorobenzyl ester derivatives by treatment with 120 µL acetonitrile, 15 µL 10% w/v pentafluorobenzyl bromide (caution, lacrimator!) in acetonitrile and 15 µL N,Ndiisopropylethylamine at 60° C for 30 min as described by Tsikas [5] . Following derivatization, the tubes were dried in a stream of nitrogen to remove excess derivatizing agent, cooled, and 0.25 mL of saturated aqueous potassium dihydrogen phosphate was added. The analytes were extracted with 2 mL of 50:50 (v/v) pentane/methylene chloride. The extracts were evaporated to dryness using a stream of nitrogen, and the analytes were dissolved in 0.15 mL of methanol for LC-MS/MS analysis.
Liquid Chromatography. The extracts (10 µL) were chromatographed with a gradient elution (aqueous methanol to 100% methanol) on a Phenomenex Synergi Polar-RP column (150 mm x 4.6 mm, 4 micron) with a flow rate of 0.7 mL/minute. The initial composition was 20% methanol, held for 1 min, which was then changed to 60% methanol over 0.1 min. This composition was held from 1.1 to 15.9 min post-injection, and then changed to 100% methanol over 0.6 min. 100% Methanol was maintained from 16.5 min to 22 min post-injection and then returned to 20% methanol to re-equilibrate the column for the next injection. Note: A Supelco HSF5 column (150 mm x 4 mm, 5 micron) can be used as an alternative to give better separation of 2-and 3-hydroxypropylmercapturic acid.
Mass Spectrometry. The mass spectrometer was operated using APCI in the negative ion mode (ECAPCI). The ion source parameters were optimized by infusing a solution of the pentafluorobenzyl ester derivative of MHBMA into the ion source via a syringe pump. The vaporizer temperature was 450° C, the heated capillary temperature was 225° C, and the corona discharge current was 50 µA. Data was acquired in the selected reaction monitoring (SRM) mode. The SRM transitions and collision energies for the analytes and internal standards are given in Table S -1. The mass resolution (FWHM) was set at 0.3 amu for Q1 and 0.7 for Q3, with the exception of PMA, for which Q1 was set at 0.1 amu, and Q3 was set at 0.7 amu.
Representative chromatograms are shown in Figure S-1 .
Data Analysis. The Finnigan XCalibur/LC Quan software was used to generate calibration curves (linear regression, 1/X weighting) and calculate concentrations using peak area ratios of analyte/internal standard (Table S- Validation. The method was evaluated for precision, accuracy, and lower limit of quantitation by replicate analysis of spiked non-smokers' urine and artificial urine samples, at concentrations spanning the expected concentration ranges (Table S-3) as described by Shah et al [6] and Viswanathan et al [7] .
Results and Discussion. Conversion of the analytes to the pentafluorobenzyl ester derivatives
and mass spectrometric analysis using ECAPCI provided high sensitivity, and for most analytes clean chromatograms (Figure S-1 ) and low limits of quantitation (Table S- Precision and accuracy met the requirements for bioanalytical methods used in drug development studies [6, 7] (Table S-3) . Concentrations and 24-hour urinary excretion for the 13 subjects are presented in Table 4 , along with published data for cigarette smokers. Concentrations and excretion in our subjects were in the ranges previously reported, but in general somewhat lower.
Likewise, concentrations of PAH metabolites were similar but somewhat lower than previously reported for cigarette smokers (Table S- 5) . This may be due to our subject population, which were water pipe smokers who also smoke cigarettes, and who smoked on average fewer cigarettes per day than the average U.S. cigarette-only smoker. The study was carried out on a research ward, which might also have affected smoking intensity.
The butadiene metabolite MHBMA deserves further discussion. It exists as multiple isomers.
Most past studies have measured a mixture of two isomers, MHBMA-1 = N-Acetyl-S-(1hydroxymethyl-2-propenyl)-L-cysteine and MHBMA-2 = N-Acetyl-S-(2-hydroxy-3-butenyl)-Lcysteine. Pure standards have generally not been available, and most investigators have used a mixture of these two and reported a sum of their concentrations. In our study, we reported concentrations of one of the two isomers. A recent publication reported that a third isomer, MHBMA-3 = N-Acetyl-S-(4-hydroxy-2-butenyl)-L-cysteine, is present in urine at higher concentrations than either MHBMA-1or MHBMA-2 [8] . In addition, this publication reported concentrations for all three isomers separately, as standards had been custom synthesized. 
